Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)

TWD 70.0

(-4.11%)

EBITDA Summary of Johnson Chemical Pharmaceutical Works Co., Ltd.

  • Johnson Chemical Pharmaceutical Works Co., Ltd.'s latest annual EBITDA in 2023 was 126.67 Million TWD , up 24.51% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 33.8 Million TWD , up 5.98% from previous quarter.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported an annual EBITDA of 101.74 Million TWD in 2022, up 29.93% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported an annual EBITDA of 78.3 Million TWD in 2021, down -13.1% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a quarterly EBITDA of 31.9 Million TWD for 2024 Q1, up 11.72% from previous quarter.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a quarterly EBITDA of 28.55 Million TWD for 2023 Q4, down -4.15% from previous quarter.

Annual EBITDA Chart of Johnson Chemical Pharmaceutical Works Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Johnson Chemical Pharmaceutical Works Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 126.67 Million TWD 24.51%
2022 101.74 Million TWD 29.93%
2021 78.3 Million TWD -13.1%
2020 90.1 Million TWD -0.99%
2019 91 Million TWD 0.0%

Peer EBITDA Comparison of Johnson Chemical Pharmaceutical Works Co., Ltd.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD 38.143%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 45.183%
Easywell Biomedicals, Inc. -85.5 Million TWD 248.16%
TTY Biopharm Company Limited 1.52 Billion TWD 91.69%
Synmosa Biopharma Corporation 1 Billion TWD 87.442%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 78.269%
Center Laboratories, Inc. -175.17 Million TWD 172.317%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -308.007%
Orient Pharma Co., Ltd. 172.39 Million TWD 26.519%
InnoPharmax Inc. -62.12 Million TWD 303.925%
Excelsior Biopharma Inc. -29.36 Million TWD 531.332%
DV Biomed Co., Ltd. 407.64 Million TWD 68.924%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 113.888%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 84.22%
UniPharma Co., Ltd. -16.25 Million TWD 879.365%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD 3.528%
Alar Pharmaceuticals Inc. 394.52 Million TWD 67.891%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 44.519%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 424.532%
Bioray Biotech Co., Ltd 12.13 Million TWD -943.906%
TSH Biopharm Corporation Limited 99.35 Million TWD -27.507%